New Policy Paper Discourages Non-Medical Switching for Asthma Patients

Treating asthma is not a one-size-fits-all exercise, as patients and clinicians well know.  So why do some health plan policies suggest otherwise? The question drives

Read More

IfPA Paper Explains How New Co-pay Coupon Rules Hurt Patients

“Not everyone can afford the medication they need,” opens a new policy brief from the Institute for Patient Access.  Co-pay coupons are one source of

Read More

Final ICER Report Leaves Cystic Fibrosis Community Uneasy

Economists at the Institute for Clinical and Economic Review advise a whopping 77 percent price discount on new CFTR modulators for cystic fibrosis, according to

Read More

Lower Drug Prices Aren’t Helping Patients

First one drug manufacturer, then another, has reported that net prices for their medications dropped last year.  And that’s good news for patients, right?  Well,

Read More

***PRESS RELEASE*** INSTITUTE FOR PATIENT ACCESS STATEMENT ON ICER’S MIGRAINE EVIDENCE REPORT

WASHINGTON – Today, the nonprofit Institute for Patient Access made the following statement regarding the Institute for Clinical and Economic Review’s (ICER) evidence report on the

Read More

What President Trump’s Drug Pricing Plan Means for Cancer Patients

As the global cancer community convenes for the annual meeting of the American Society of Clinical Oncology, one question looms large: What will President Donald

Read More

New Paper Explains How Barriers, Cost Hinder Diabetes Care

Diabetes is becoming more common.  But access to appropriate care for people living with diabetes?   Not so much. So explains a new white paper from

Read More

Tourette Syndrome Awareness Month: A Time to Stop the Stigma

Many people think they know Tourette syndrome.  It’s the person who blurts out foul words at inopportune times, like what you see on sitcoms or

Read More

Cystic Fibrosis Patients Assert Health Care Rights

Certain elements are critical to the health care that patients with cystic fibrosis need.  The Cystic Fibrosis Engagement Network has identified those elements in its

Read More

ICER Report Offers Little for Women with Endometriosis

Only one-fourth of the 6 million women with endometriosis could be treated with a new GnRH antagonist and still meet the Institute for Clinical and

Read More
Back to Top